← Retour au Screener

Sector: Santé
Open in Terminal → NNOXLive chart · Key metrics · News · Smart money

Nano-X Imaging

NNOX Micro Cap

Healthcare · Medical Devices

Mis à jour: Aug 2, 2026, 22:14 UTC

0,85 €
+1.54% aujourd'hui
52W: 0,63 € – 4,29 €
52W Low: 0,63 € Position: 5.8% 52W High: 4,29 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
P/E prévisionnel
P/S Ratio
4.7x
Cours/Ventes
EV/EBITDA
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
59 M €
Capitalisation boursière
Croissance du CA
53.1%
Croissance du CA sur un an
Marge bénéficiaire
Marge nette
ROE
-50.12%
Rentabilité des capitaux propres
Beta
1.23
Sensibilité au marché
Positions vendeuses
10.38%
% du flottant vendu à découvert
Volume moyen
2,070,048
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
3 analysts
Avg. Price Target
4,45 €
+423.86% upside
Target Range
2,60 € – 6,42 €

About the Company

Sector: Healthcare Industry: Medical Devices Country: Israel Employees: 197 Exchange: NGM

Nano-X Imaging en bref

Nano-X Imaging (NNOX) is currently trading at 0,85 € with a market capitalization of 59 M €. The 52-week range spans from 0,63 € to 4,29 €; the current price is 80.2% below the yearly high. Year-over-year revenue growth stands at +53.1%.

💰 Dividende

Nano-X Imaging currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

3 analystes évaluent Nano-X Imaging (NNOX) au consensus : None. L'objectif de cours moyen est de 4,45 €, soit un potentiel de +423.86% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 2,60 € à 6,42 €.

Nano-X Imaging : la thèse d'investissement en détail

Nano-X Imaging (NNOX) operates in the Healthcare — specifically Medical Devices — and is headquartered in Israel. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 53.1% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind.

Le scénario baissier

Short interest sits at 10.38% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

  • The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
  • The analyst consensus price target implies 423.86% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Forte croissance du CA de 53.1% sur un an
  • Bilan solide avec faible endettement (D/E 6.05)
Points faibles
  • Positions vendeuses élevées (10.38%)
  • Free cash flow négatif

Aperçu technique

MM 50 jours
1,24 €
-31.47% vs. cours
MM 200 jours
2,14 €
-60.32% vs. cours
Sous le plus haut 52s
−80.2%
4,29 €
Au-dessus du plus bas 52s
+34.2%
0,63 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

Risque de marché (Bêta)
1.23 · Élevé
Évolue plus que le marché global
Positions vendeuses
10.38% · Élevé
% du flottant vendu à découvert
Dette/Capitaux propres
6.05 · Faible
Dette totale / capitaux propres

The data points to market-like volatility, elevated short interest (10.38%).

Trading Data

50-Day MA: 1,24 €
200-Day MA: 2,14 €
Volume: 396,753
Avg. Volume: 2,070,048
Short Ratio: 1.89
P/B Ratio: 0.49x
Debt/Equity: 6.05x
Free Cash Flow: -25 075 649 €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Nano-X Imaging?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut